Monthly Archives: June 2016

DEADLINE APPROACHING: Lundin Law PC Announces Securities Class Action Lawsuit Against Express Scripts Holding Company and Reminds Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / June 23, 2016 / Lundin Law PC announces a class action lawsuit has been filed against Express Scripts Holding Company (“Express Scripts” or the “Company”) (NASDAQ: ESRX) concerning possible violations of federal securities laws between February 24, 2015 and March 21, 2016. Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the July 5, 2016, lead plaintiff motion deadline.

To participate in this class action lawsuit, please contact Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or via e-mail at brian@lundinlawpc.com.

No class has been certified in the above action. Until a class is certified, you are not considered represented by an attorney. You may also choose to do nothing and be an absent class member.

According to the complaint, Express Scripts failed to disclose that it was experiencing serious operational issues that interfered with its ability to sufficiently serve Anthem and exposed Anthem to increased regulatory scrutiny. When the truth was revealed, shares dropped causing investors harm.

Lundin Law PC was created by Brian Lundin, a securities litigator based in Los Angeles.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contact:

Lundin Law PC
Brian Lundin, Esq.
Telephone: 888-713-1033
Facsimile: 888-713-1125
brian@lundinlawpc.com

SOURCE: Lundin Law PC

ReleaseID: 441597

CPI CARD GROUP DEADLINE ALERT: Khang & Khang LLP Announces The Filing Of A Securities Class Action Lawsuit Against CPI Card Group Inc. And Reminds Investors With Losses To Contact The Firm

IRVINE, CA / ACCESSWIRE / June 23, 2016 / Khang & Khang LLP (the “Firm”) announces that a class action lawsuit has been filed against CPI Card Group Inc. (“CPI” or the “Company”) (Nasdaq: PMTS). Investors who purchased or otherwise acquired shares traceable to the Company’s October 8, 2015, initial public offering (“IPO”), are encouraged to contact the Firm prior to the lead
plaintiff motion deadline.

If you purchased shares of CPI during the Class Period, please contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or by email at joon@khanglaw.com.

There has been no class certification in this case. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.

According to the complaint, the Company failed to disclose that CPI disseminated more than 100 million more cards than its biggest customers were using in the second and third quarters of 2015. This created a huge backlog which resulted in a substantial reduction of demand for additional cards for the remainder of the 2015 fiscal year. When the truth was revealed, shares dropped causing investors harm.

If you wish to learn more about this lawsuit, or if you have any questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or by email at joon@khanglaw.com.

This press release may constitute Attorney Advertising in some jurisdictions.

Contact:

KHANG & KHANG LLP
Joon M. Khang, Esq.
Telephone: 949-419-3834
Facsimile: 949-225-4474
joon@khanglaw.com

SOURCE: Khang & Khang LLP

ReleaseID: 441596

As Xarelto Lawsuit Filings Continue New Evidence Surfaces Surrounding Clinical Trials

June 23, 2016 – – TheProductLawyers.com explores evidence detailed in an article from Business Insider (BI) that bolsters claims of an exacerbated risk of bleeding associated with Xarelto. While the new-generation anticoagulant from Bayer AG and Janssen Pharmaceuticals received FDA approval in 2011, complications with its use have led to intense scrutiny from both public and private sectors.

Initially, both patients and doctors welcomed the new-generation anticoagulant. It lacked the dietary restrictions that accompanied the old guard of blood-thinning medications and required none of the meticulous dosage adjustments or constant monitoring. Physicians prescribed it to those recovering from hip or knee surgeries and individuals with an increased potential for stroke because it acted to prevent clotting in the bloodstream. This also made it ideal for patients who suffered from deep vein thrombosis or pulmonary embolism.

Since 2011, Bayer AG and Janssen Pharmaceuticals have reaped the considerable benefits of this wunderkind, drawing $1.8 billion from the U.S. market alone in 2015. However, the mounting litigation has exceeded 5,000 individual suits, according to BI. Among those lawsuits, ten percent extend the claim of harm to that of death.

According to the article, the controversy surrounding Xarelto surged dramatically following the revelation that the manufacturers potentially falsified clinical trial data. Tests were conducted using a subsequently recalled blood-monitoring device. Katie Thomas of the New York Times asserts that there’s also evidence that the pharmaceutical companies knowingly withheld crucial data from peer reviewers at the New England Journal of Medicine. This accusation is neither made nor taken lightly, and sets an ominous tone for future inquiries.

While the investigation is ongoing, revealed flaws in the clinical trials of Xarelto have brought official scrutiny to bear. Both the U.S. FDA and the European Medicine Agency are probing deeply into the data, as well as the role of the recalled blood-monitoring device in the integrity of the trials. Pending the results of their inquiries, it may also call into question the legitimacy of the 2011 FDA approval.

The attorneys of Banville Law, the firm behind TheProductLawyers.com, are offering complimentary consultations to anyone who suffered injury or hospitalization after a bleed while on Xarelto. For more information about this release or the Xarelto litigation call 888-997-3792.

###

Contact TheProductLawyers.com:

Banville Law
888-997-3792
info@banvillelaw.com
165 West End Ave #1h,
New York, NY 10023

ReleaseID: 60010976

Construction Accident Lawyer Supports OSHA’s Final Ruling On Modernizing Injury Data Collection

June 23, 2016 – – LipsigLawyers.com’s Thomas Moverman recently commented on May 11th’s announcement from the Occupational Safety & Health Administration which focused on the modernization of injury data collection. Moverman noted that this recent step from the organization should generate a more informed public, and hopefully will allow current workers to truly understand the potential dangers that they could face while on the job.

A news report by ConstructionEquipment.com outlined the potential effects of the new rule, that has the goal of improving workplace safety and minimizing future illnesses. The article states that OSHA expects public disclosure of workplace data to encourage employers to increase their efforts to maintain a safe worksite, and minimize potential risk factors.

The assistant secretary of labor for OSHA explained that “Since high injury rates are a sign of poor management, no employer wants to be seen publicly as operating a dangerous workplace.” Therefore, he speculates that employers should be encouraged to do everything in their power to provide a safe workplace and adhere to all safety rules and regulations.

This announcement stems from a report from The Bureau of Labor Statistics (BLS) that reports that more than 3 million workers suffer a workplace injury or illness each year. The BLS also reports that there were nearly 5,000 fatal occupational injuries, nearly 1,200 in transportation incidents and almost 900 in construction accidents in 2014. OSHA has the hope that with this new rule requiring public data collection and sharing, that the frequency of fatal occupational injuries will decrease as a result of employers seeking positive public exposure.

Lipsig, Shapey, Manus, & Moverman applaud OSHA on issuing this final ruling and hope that it will have the intended effects that OSHA predicted. However, the law firm notes that in 2014 there was the largest number of fatalities in one year since 2008, and feels that construction accident victims deserve proper representation. The firm is currently offering all victims complimentary legal consultations. Attorney Thomas Moverman has an impressive record representing previous victims, such as securing one victim a $2,500,000 compensation, after the victim fractured his leg and severely injured his back.

For more information on construction injuries, or for a consultation, contact an attorney with Lipsig, Shapey, Manus & Moverman at (646)-846-4496.

###

Contact LipsigLawyers.com:

Marc Freund
877-711-9545
mfreund@lipsig.com
40 Fulton St, New York, NY 10038

ReleaseID: 60010958

Flaws In Research Design Come To Light As Xarelto Lawsuit Filings Grow In Number

June 23, 2016 – – TheProductLawyers.com comments on a recently published article from Business Insider (BI) detailing new evidence in the case against Xarelto. The FDA approved the new-generation anticoagulant from Bayer AG and the Johnson & Johnson subsidiary company, Janssen Pharmaceuticals, in 2011. However, an increasing number of lawsuits claiming increased risk of internal bleeding associated with Xarelto has drawn scrutiny from both public and official quarters.

Initially, the drug was heralded as a major breakthrough in the treatment of patients who suffered from pulmonary embolism or deep vein thrombosis. Physicians also prescribed it to those at an increased risk of stroke or patients recovering from hip and knee surgery precisely because of its purported clot prohibiting qualities. It was preferred by many over anticoagulants with a longer history of use, primarily because it did not require the intensive monitoring, dosage alteration, and dietary restrictions associated with more established drugs.

The $1.8 billion in profits drawn by the pharmaceutical giants in 2015 is overshadowed by the large number of lawsuits filed against them. BI reports that more than 5,000 lawsuits have been brought against the companies, with allegations of serious harm. Of those, a staggering ten percent allege that use of the drug caused death. According to the article, a recently released document suggests that the manufacturers of the drug knowingly withheld key data from clinical trials, thus falsifying the findings of peer-reviewed research.

Results reported to the New England Journal of Medicine were based on a subsequently recalled blood-monitoring device, according to Katie Thomas of the New York Times. If the federal legal brief from which she gleaned this information is accurate, such a revelation calls into serious question the accuracy of the reported clinical tests conducted by the manufacturers.

As the lawsuits move forward, the findings have caused both the FDA and the European Medicine Agency to delve more deeply into the matter. Reviews of the available data are expected, as well as official consideration of whether the 2011 approval of Xarelto was premature.

The attorneys of Banville Law, the firm behind TheProductLawyers.com, are offering complimentary consultations to anyone who suffered injury or hospitalization after a bleed while on Xarelto. For more information about this release or the Xarelto litigation call 888-997-3792.

###

Contact TheProductLawyers.com:

Banville Law
888-997-3792
info@banvillelaw.com
165 West End Ave #1h,
New York, NY 10023

ReleaseID: 60010975

One of Portland’s Nursing Staffing Agencies Receives Gold Star Rating on Audit

June 23, 2016 – – Tualatin, Ore. – Express Healthcare Professionals, one of the most popular nursing staffing agencies in Portland, OR, passed their second on site review with the Joint Commission with flying colors.

On Friday, June 3, the Express Healthcare Professional office was visited by the Joint Commission for their second on site review, a biennial unannounced audit of the office’s policies, procedures, files, and operations. The office’s 100% gold star rating from the commission renewed their accreditation for the next two years.

“We are excited about the changes,” says Julie Tate, the Managing Partner of Express Employment Professionals. “Now we can take a breath and enjoy our summer now that the unannounced visit is over for 2 more years!”

Certifying close to 21,000 healthcare organizations a year, The Commission itself works to continuously improve healthcare standards for the public by evaluating these organizations and encouraging them to provide safe and effective care.

About Express Healthcare Professionals

The company located in Tualatin, OR, is a leading company among Medical Staffing Agencies in Portland, OR and helps clinicians find contract positions across Portland and surrounding areas.

The Express Healthcare Professionals office is located at 7401 SW Washo Ct and serves the Portland Metro Area. Local businesses and applicants are encouraged to stop by, visit www.ExpressHealthcareNW.com or call (503) 272-6386.

###

Contact Express Healthcare Professionals:

Julie Tate
(503) 272-6386
ExpressPros.Healthcare@gmail.com
7401 SW Washo Ct #101
Tualatin, OR 97062

ReleaseID: 60010987

Livermore Roofers Extends Services Beyond Roof Repairs

June 23, 2016 – – Livermore Roofers, a company based in Livermore, CA, has announced that they have extended their range of services to go beyond roof repairs. This is because when roofs are damaged, it is not uncommon for other elements of a property to be damaged as well. Their services now include window replacement, outside property painting, and rain gutter fixes and installation. All of these added services are usually needed by homes that need roof repair either due to storm damage or the advancing years of the property. Full details about their services can be viewed on their website at http://www.livermoreroofers.com.

James Grant from Livermore Roofers says: “We are master contractors in supplying household as well as industrial roof covering options, from asphalt roof shingles, metal roof covering, to the most up to date energy-efficient membranes for office roof coverings. However, many of our clients have been requesting additional kinds of work. Thus, we had to expand our services.”

The company provides all types of roofing solutions for residential properties, such as rock coated steel, asphalt shingles, low incline applications, concrete ceramic tile, asbestos reduction, and synthetics. With the addition of the other services, the company wants to set itself apart by being a quality provider of home repair services. Since the company started, they have had a strong focus on customer care, offering uncompromising high quality and an excellent attention to detail. The company has already received numerous awards and certifications to highlight this, as well as various written and video testimonials.

Another thing that makes this company unique is that they are committed to creating a workplace in which employees feel supported and rewarded for their hard work. They want to foster integrity and a positive attitude. To achieve this, they want to remain fully up to date with the latest technologies and techniques now not just in roof repair, but also in their other new services.

People who feel they require any of the company’s services, whether after a storm or not, are encouraged to contact them using their website, where an easy to use contact form has been included. Offering free, no obligation quotations, Livermore Roofers wants to make sure people know exactly where they stand.

###

Contact Livermore Roofers:

James Grant
888-515-9283
info@livermoreroofers.com
Suite 2267, 2205-2299 Las Positas Road, Livermore, CA 94551

ReleaseID: 60010895

Pay Per Call Marketing Announces New Digital Marketing Services To London Businesses

June 23, 2016 – – Pay Per Call Marketing, which is based in London, England, has announced that they now provide simplified digital marketing services for local businesses. The company explains that the new services are designed for businesses that are struggling to generate new leads through the internet.

Sam Adodra, spokesperson for Pay Per Call Marketing, states, “We will take care of search engine optimization, pay per click, Facebook advertising, and other forms of lead generation to remove the hassle of local businesses employing separate marketing consultants for each of these services.”

The company understands that local business owners get targeted by marketing agencies several times a week and are often confused by what service to go for. Adodra states that what sets their company apart from others is how they perform their services.

“We only offer live phone calls from interested customers,” says Adodra. “This way, you know that you’re getting people who are honestly interested in what you’re offering.”

Adodra says that companies today are finding it more and more difficult to generate quality leads, and that most other marketing services simply push off generic leads that most of the time have no interest in what the business is offering. He states that those obtaining quality leads are much more likely to see those leads turn into new customers, which is what the company strives to accomplish in every project they undertake.

Adodra adds that it is becoming much harder today for offline businesses to reach their targeted audiences. He states that people rarely use the Yellow Pages or other directories these days and instead, opt for the internet to help them find the local business that they need. Because consumers today are using a variety of methods to access the internet, they are much more likely to turn online when researching local facilities, which makes it crucial for local businesses to have an online presence.

Pay Per Call Marketing offers a variety of strategies to help local companies to get their businesses noticed by the very people who need what they are offering. More about the company and the services that they provide can be seen on their official website at http://www.paypercallmarketing.org.

###

Contact Pay Per Call Marketing:

Sam Adodra
020 8938 3645
info@paypercallmarketing.org
3rd Floor, 207 Regent Street, London W1B 3HH

ReleaseID: 60010896

Migration Complications: Complications Of An Adverse Event Mentioned In IVC Filter Lawsuit Filings

June 23, 2016 – – TheProductLawyers.com reports on complications associated with device migration, an adverse event cited in several IVC filter lawsuit filings. Device migration occurs when an IVC filter is placed in the body and it moves from its original insertion point. Studies suggest that while older models were made of stainless steel or titanium, new retrievable IVC filters come in a variety of cutting-edge alloys with “shape memory.” The filters tend to become flexible in colder temperatures and when heated, they return to their original shape. Thus fluctuations in body temperature can alter an IVC filter’s configuration, allowing it to detach from the vena cava and flow “upstream.”

There are several complications associated with filter migration. According to Michigan’s William Beaumont Hospital, one case in which a 54-year-old man had the device implanted resulted in the filter moving to the right ventricle of his heart. He suffered from an abnormally rapid heart rate and was subsequently diagnosed with non-Q-wave myocardial infarction, a less severe form of heart attack. Symptoms of filter migration typically include chest pain, palpitations, fainting and abnormal heart rhythms.

IVC filters are made to capture blood clots in patients at high risk. The devices are meant to prevent blood clots from moving to other parts of the body and are usually given to patients who may not be able to take anticoagulants. The devices, however, have recently come under fire, with patients claiming that they cause serious adverse events such as device migration. These patients in many cases have also filed lawsuits against companies such as C.R. Bard and Cook Medical claiming that they knew about the defects. Hundreds of these cases have accumulated so far and have been combined into MDLs in Arizona and Indiana.

As these cases are expected to accumulate, Banville Law is looking to assist those individuals who believe they have suffered significantly from the use of an IVC filter.The firm strongly believes in leveling the playing field by pursuing justice for those who have been affected by dangerous devices or drugs. Qualifying persons may be entitled to legal action and significant financial compensation. Banville Law has years of experience fighting large pharmaceutical companies who have put dangerous drugs or devices into the market.

For more information on IVC filters, to ask questions or to schedule a consultation, contact an attorney at Banville Law by calling (888) 997-3792.

###

Contact TheProductLawyers.com:

Banville Law
888-997-3792
info@banvillelaw.com
165 West End Ave #1h,
New York, NY 10023

ReleaseID: 60010960

DEVRY DEADLINE APPROACHING: Lundin Law PC Announces Securities Class Action Lawsuit Against DeVry Education Group, Inc. And Reminds Investors With Losses To Contact The Firm

LOS ANGELES, CA / ACCESSWIRE / June 23, 2016 / Lundin Law PC announces a class action lawsuit has been filed against DeVry Education Group, Inc. (“DeVry” or the “Company”) (NYSE: DV) concerning possible violations of federal securities laws between February 4, 2011 and January 27, 2016. Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the July 12, 2016, lead plaintiff motion deadline.

To participate in this class action lawsuit, please contact Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or via e-mail at brian@lundinlawpc.com.

No class has been certified in the above action. Until a class is certified, you are not considered represented by an attorney. You may also choose to do nothing and be an absent class member.

According to the complaint, the Company failed to disclose that: (1) the Company was involved in a prolonged deceptive advertising campaign; and (2) DeVry exaggerated its students’ ability to secure jobs after graduation.

Lundin Law PC was created by Brian Lundin, a securities litigator based in Los Angeles.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contact:

Lundin Law PC
Brian Lundin, Esq.
Telephone: 888-713-1033
Facsimile: 888-713-1125
brian@lundinlaw.com

SOURCE: Lundin Law PC

ReleaseID: 441595